Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization

Fertil Steril. 2008 Jun;89(6):1694-701. doi: 10.1016/j.fertnstert.2007.05.055. Epub 2008 Apr 28.

Abstract

Objective: To determine if attempts to maximize oocyte yield during ovarian stimulation translates into improved outcome of in vitro fertilization (IVF) cycles.

Design: Retrospective study.

Setting: Academic tertiary care IVF center.

Patient(s): 806 de-identified nondonor IVF cycles.

Intervention(s): Evaluation of fresh nondonor IVF cycles (n = 806) for the period January 1, 1999, to December 30, 2001.

Main outcome measure(s): Cycle cancellation, clinical pregnancy, spontaneous miscarriage, and live birth after IVF.

Result(s): Advancing age, independent of ovarian reserve status (reflected by early follicular phase FSH and estradiol) augured a worse prognosis for all outcomes. Higher gonadotropin use lowered cycle cancellations but was associated with a statistically significantly reduced likelihood of clinical pregnancy and live birth and a trend toward a higher likelihood for spontaneous miscarriage after IVF.

Conclusion(s): Our data add to the accruing literature suggesting adverse influences of excess gonadotropin use on IVF outcomes. Although an aggressive approach to controlled ovarian hyperstimulation results in a statistically significant reduction in cycle cancellations, the excessive use of gonadotropins detrimentally influences live birth after IVF.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Cryopreservation
  • Dose-Response Relationship, Drug
  • Embryo Transfer
  • Estradiol / blood
  • Female
  • Fertilization in Vitro / methods*
  • Follicle Stimulating Hormone / blood
  • Gonadotropins / adverse effects*
  • Gonadotropins / therapeutic use*
  • Humans
  • Infertility, Female / etiology
  • Infertility, Female / therapy
  • Middle Aged
  • Oocyte Retrieval
  • Ovarian Hyperstimulation Syndrome / prevention & control*
  • Ovulation Induction / methods*
  • Pregnancy
  • Pregnancy Outcome

Substances

  • Gonadotropins
  • Estradiol
  • Follicle Stimulating Hormone